PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
inFlow Inventory launches lot number and expiry date tracking
2026-08-20T    Health Care/Hospital   Medical/Pharmaceuticals 
Zylox-Tonbridge Delivers Strong First-Half 2026 Results as International Revenue Surges 349%
2026-08-20T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Apollo Hospitals launches 'Always Open, Always Here', a global first in healthcare from India
2026-08-20T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Matwings Demonstrates Closed-Loop Protein AI Through Four AI-Wet Lab Cycles and 222 Protein Variants
2026-08-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ISoOR 2026 Organoid Clinical Transformation Summit convened in Hangzhou
2026-08-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals   Trade show news 
Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline
2026-08-20T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Pillar Biosciences, LC-SCRUM-Asia and LSI Medience Announce Liquid Biopsy Screening Collaboration in Lung Cancer
2026-08-20T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
XtalPi Holdings Announces 2026 Interim Results
2026-08-19T    Biotechnology   Medical/Pharmaceuticals 
DrFirst Receives Frost & Sullivan's 2026 North America Enabling Technology Leadership Recognition for Advancing AI-Enhanced Medication Orchestration
2026-08-19T    Health Care/Hospital   Medical/Pharmaceuticals 
ZEISS CLINIC 360 receives FDA 510k clearance, amplifying patient care through simplified clinical insights
2026-08-19T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.